Developing Resilience and Anxiety Management Through the Arts

NCT07033052 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-07-20

No results posted yet for this study

Summary

The Developing Resilience and Anxiety Management Through the Arts (DRAMA) Study examines the degree to which the arts can help to address stress, anxiety, and sad mood in children and adolescents. The researchers will pair theatrical improvisation exercises with cognitive-behavioral therapy (CBT) techniques versus improvisation exercises alone versus a social craft group on reducing elevated levels of anxiety and depression.

Conditions

Interventions

BEHAVIORAL

Improvisation + Wellness

Theatrical improvisation exercises, the theatrical art of performance and storytelling without a script, will be combined with wellness techniques

BEHAVIORAL

Improvisation

Theatrical improvisation exercises (the theatrical art of performance and storytelling without a script) will be completed in this arm. These exercises will be fairly similar to that from the improvisation + wellness but without the wellness techniques.

BEHAVIORAL

Social Craft

Participants assigned to the Social Craft group will engage in arts and crafts projects and activities

Sponsors & Collaborators

  • Expanding Horizons Initiative

    collaborator UNKNOWN
  • Case Western Reserve University

    lead OTHER

Principal Investigators

  • Amy Przeworski, PhD · Case Western Reserve University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2027-07-01
Completion
2027-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07033052 on ClinicalTrials.gov